Table 5.
Obstetric, delivery and neonatal outcomes of 57 pregnant women who received two doses of BNT162b2 vaccine
Outcome | Value |
---|---|
Gestational age at birth (weeks) | 39.5 (38.7–40.0) |
Premature delivery < 37 weeks | 0 (0) |
Birth weight (g) | 3269 ± 410 |
Miscarriage or IUFD | 0 (0) |
PIH or pre‐eclampsia | 1 (1.8) |
SGA | 3 (5.3) |
Gestational diabetes | 4 (7.0) |
Placental abruption | 2 (3.5) |
Oligohydramnios | 1 (1.8) |
Polyhydramnios | 2 (3.5) |
Induction of labor | 17 (29.8) |
Vacuum/forceps‐assisted delivery | 2 (3.5) |
Elective Cesarean section | 3 (5.3) |
Emergency Cesarean section | 7 (12.3) |
Postpartum hemorrhage | 6 (10.5) |
Endometritis | 1 (1.8) |
Neonatal death | 0 (0) |
Neonatal CPR | 0 (0) |
Neonatal oxygen support | 2 (3.5) |
Neonatal invasive ventilation | 2 (3.5) |
Neonatal fever | 0 (0) |
NICU hospitalization* | 2 (3.5) |
Data are given as median (interquartile range), n (%) or mean ± SD.
Two neonates were hospitalized in neonatal intensive care unit (NICU) after birth, both due to requirement for invasive ventilation; one of them was diagnosed with respiratory distress syndrome.
CPR, cardiopulmonary resuscitation; IUFD, intrauterine fetal demise; PIH, pregnancy‐induced hypertension; SGA, small‐for‐gestational age (birth weight < 10th centile).